Initial experience and lessons learned with implementing Lutetium-177-dotatate radiopharmaceutical therapy in a radiation oncology-based program.

Autor: Maughan NM; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO. Electronic address: Maughan.nichole@wustl.edu., Kim H; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO., Hao Y; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO., Unangst S; School of Medicine, University of Missouri, Columbia, MO., Roach MC Jr; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO., Garcia-Ramirez JL; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO., Amurao M; Radiation Safety Division, EH&S Department, Washington University in St. Louis, St Louis, MO., Luechtefeld D; Radiation Safety Division, EH&S Department, Washington University in St. Louis, St Louis, MO., Abdin K; Radiation Safety Division, EH&S Department, Washington University in St. Louis, St Louis, MO., Altman MB; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO., Banks A; Department of Radiation Oncology, Barnes Jewish Hospital, St. Louis, MO., Riepe M; Department of Radiation Oncology, Barnes Jewish Hospital, St. Louis, MO., Bovard E; Department of Radiation Oncology, Barnes Jewish Hospital, St. Louis, MO., Jenkins S; Department of Radiation Oncology, Barnes Jewish Hospital, St. Louis, MO., Zoberi JE; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.

Publikováno v: Brachytherapy [Brachytherapy] 2021 Jan-Feb; Vol. 20 (1), pp. 237-247. Date of Electronic Publication: 2020 Aug 17.